MENU
+Compare
LENS
ETF ticker: BATS
AS OF
Dec 24 closing price
Price
$39.57
Change
-$0.24 (-0.60%)

LENS stock forecast, quote, news & analysis

The investment seeks to achieve long-term capital appreciation... Show more

LENS
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for LENS with price predictions
Dec 24, 2025

LENS's RSI Oscillator peaks and leaves overbought zone

The 10-day RSI Indicator for LENS moved out of overbought territory on December 24, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 4 instances where the indicator moved out of the overbought zone. In of the 4 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LENS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

LENS broke above its upper Bollinger Band on December 22, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 26, 2025. You may want to consider a long position or call options on LENS as a result. In of 12 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for LENS just turned positive on November 26, 2025. Looking at past instances where LENS's MACD turned positive, the stock continued to rise in of 6 cases over the following month. The odds of a continued upward trend are .

LENS moved above its 50-day moving average on November 24, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LENS advanced for three days, in of 48 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 67 cases where LENS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Exxon Mobil Corp (NYSE:XOM), GE Aerospace (NYSE:GE), Chevron Corp (NYSE:CVX), BHP Group Limited (NYSE:BHP), Petroleo Brasileiro Sa-Petrobras ADS (REP 1 Common Share) (NYSE:PBR), Freeport-McMoran (NYSE:FCX), Vale SA (NYSE:VALE), Wheaton Precious Metals Corp (NYSE:WPM), Diamondback Energy (NASDAQ:FANG), Gold Fields Ltd (NYSE:GFI).

Industry description

The investment seeks to achieve long-term capital appreciation. The fund is an actively managed exchange-traded fund (“ETF”) that will invest primarily in domestic and foreign equity securities of companies considered by Sarmaya Partners, LLC, the sub-adviser to the fund (the “Sub-Adviser”), to reflect an emerging or prevailing market theme. The Sub-Adviser defines “emerging or prevailing market theme” as market sectors, asset classes, or regions that are believed to be poised for future growth through the market cycle (i.e, the period of time between two major lows for a market. The fund is non-diversified.

Market Cap

The average market capitalization across the Sarmaya Thematic ETF ETF is 82.88B. The market cap for tickers in the group ranges from 149.3M to 502.77B. XOM holds the highest valuation in this group at 502.77B. The lowest valued company is GTE at 149.3M.

High and low price notable news

The average weekly price growth across all stocks in the Sarmaya Thematic ETF ETF was 3%. For the same ETF, the average monthly price growth was 12%, and the average quarterly price growth was 40%. CCO experienced the highest price growth at 12%, while PSQ experienced the biggest fall at -5%.

Volume

The average weekly volume growth across all stocks in the Sarmaya Thematic ETF ETF was -55%. For the same stocks of the ETF, the average monthly volume growth was -44% and the average quarterly volume growth was -67%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 50
Price Growth Rating: 46
SMR Rating: 62
Profit Risk Rating: 32
Seasonality Score: 32 (-100 ... +100)
View a ticker or compare two or three
LENS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

an ophthalmic device company

Category ForeignLargeBlend

Profile
Fundamentals
Details